Financial Instruments Business Operator Kanto Finance Bureau Director (Kinsho) No. 1960 / Membership Association Investment Trusts Association, Japan Membership No. 012-02323 Go to GogoJungle Home
icon List
イチロウ
10/23/2026 07:30
Release： 10/23/2026 07:30
Update： 10/23/2026 07:30
イチロウ
Investment style : Fundamental
Investment career : 3-5 years
Investment amount : -
ICHIRO｜Financial Report Anatomy Lab I am a researcher who dissects not the surface numbers of a company, but the underlying structure and truth hidden behind them. I provide a genuine fundamentals analysis that thoroughly reads every detail of a company's financial statements (P/L, B/S, C/F, S/S) and notes, not aiming for a one-shot turnaround tool or short-term speculative trades. ■ Our Lab’s Stance 1. Complete coverage of the four financial statements We unravel the connections among the income statement (P/L), balance sheet (B/S), cash flow statement (C/F), and statement of changes in equity (S/S). 2. Extracting the anomalies and truths hidden in the notes Beyond superficial profit increases or decreases, we delve into notes and fine-grained data to visualize the structural strengths of the business model and hidden risks. 3. Fact-focused with noise eliminated We exclude vague forecasts and hype, conducting objective and logical analyses based on the confirmed facts in the financial statements. ■ Delivery and Sales Content ・Financial Statement Anatomy Reports (latest financial reports of notable companies) ・“Financial Analysis Key Points” explained from zero accounting knowledge (without using complex accounting theories, identifying the core of the financial statements and any inconsistencies) We deliver information for genuine-minded investors and business professionals who want to see the truth behind a company’s financials without requiring difficult bookkeeping knowledge.
Article cover image

[Estée Lauder Thorough Analysis Part 3]: The looming deadline behind a 10,000 layoffs — a razor-thin defense line and a rating cliff edge

ICHIRO｜Financial Statement Anatomy Lab


In the second installment, we verified that Estée Lauder Companies Inc.'s “dramatic return to profitability” was a financial illusion created by the elimination of a huge impairment booked in the previous period (about $1.3 billion), with the actual improvement in core business being extremely limited.

However, the true challenge facing the company is not the appearance of the income statement (P/L). It lies in the deterioration of assets lurking on the balance sheet (B/S) and the countdown quietly ticking away behind the cash flow statement (C/F) toward debt repayment and cash outflow deadlines.

In the third installment, by cross-checking the B/S and C/F of the Fiscal 2026 Form 10-K for the year ended June 30, 2026, we will dissect the extremely fragile defense line the company stands on and the financial necessity that forced it to undertake a workforce reduction of about 10,000 employees (PRGP).

This time, the past articles on Estée Lauder from our corporate analysis series are here?

【Estée Lauder Thorough Analysis Part 1】: How Estée Lauder makes money — the fame of a 75% gross margin and the trap of massive fixed costs

【Estée Lauder Thorough Analysis Part 2】: Exposing the lie of the “dramatic V-shaped recovery” — the accounting magic of a $1.3 billion impairment vanishing


From here, the past articles in the Home Depot analysis series are here?

【Home Depot Thorough Analysis Part 1】: The current state of the U.S. housing market enduring price hikes despite a drop in customer count — the hidden truth behind a 10% net profit margin

【Home Depot Thorough Analysis Part 2】: From “stores” to “BtoB wholesale” — the labyrinth of a massive M&A and a sharp rise in receivables on the path to dominating the professional market

【Home Depot Thorough Analysis Part 3・Final】: The paradox of a 15% equity ratio — why did they pay off debt by stopping annual $10 billion in share buybacks?